Supernus Pharmaceuticals, Inc. (SUPN): $30.70

-0.25 (-0.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Supernus Pharmaceuticals Inc (SUPN) Price Targets From Analysts

Use the tables below to see what analysts covering Supernus Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
4 $35 $25 $30.75 $31.85 -3.45%

The Trend in the Analyst Price Target


Over the past 39 days, SUPN's average price target has gone down $0.25.

Over the past 293 days, SUPN's average upside potential has been 15.71%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-05-28 3 33 24 27.33 24.500 11.55%
2020-06-12 4 33 24 28.00 22.830 22.65%
2020-06-29 4 33 24 28.00 23.270 20.33%
2020-07-20 4 33 24 28.00 24.220 15.61%
2020-07-24 4 33 24 29.00 23.280 24.57%
2020-08-19 4 35 24 29.25 23.400 25%
2020-09-18 4 35 22 28.75 22.350 28.64%
2020-10-07 4 35 22 28.75 20.875 37.72%
2020-11-09 4 35 21 27.75 24.950 11.22%
2020-11-28 4 35 21 27.75 21.870 26.89%
2020-12-07 4 35 21 27.75 21.500 29.07%
2020-12-09 4 35 21 27.75 21.970 26.31%
2020-12-19 4 35 21 27.75 21.880 26.83%
2020-12-26 4 35 21 27.75 25.660 8.14%
2021-01-02 4 35 21 27.75 25.160 10.29%
2021-01-09 4 35 21 27.75 27.260 1.8%
2021-01-16 4 35 26 29.75 29.220 1.81%
2021-01-23 4 35 26 29.75 29.940 -0.63%
2021-01-30 4 35 26 29.75 29.390 1.22%
2021-02-06 4 35 26 31.00 29.420 5.37%
2021-02-13 4 35 26 31.00 30.570 1.41%
2021-02-20 4 35 26 31.00 29.610 4.69%
2021-02-27 4 35 25 30.75 26.870 14.44%
2021-03-06 4 35 25 30.75 25.145 22.29%
2021-03-13 4 35 25 30.75 26.705 15.15%
2021-03-17 4 35 25 30.75 26.460 16.21%

SUPN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.75 0 2 2 0 0 4

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SUPN as an investment opportunity.

  • The upside potential (average analyst target price relative to current price) of SUPN is higher than 23.24% of all US stocks.
  • Supernus Pharmaceuticals Inc's number of analysts covering the stock is higher than 19.94% of stocks in the mid market cap category.
  • Supernus Pharmaceuticals Inc's variance in analysts' estimates is less than 63.1% of Pharmaceutical Products stocks.
  • Supernus Pharmaceuticals Inc's average analyst price target is greater than 61.79% of Pharmaceutical Products stocks.

Stocks similar to Supernus Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CORT, ANAB and VSTM.

What is the outlook for SUPN? Use POWR Ratings for clearer insight into price direction.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7658 seconds.